▶ 調査レポート

塞栓術粒子のグローバル市場2021

• 英文タイトル:Global Embolization Particle Sales Market Report 2021

QYResearchが調査・発行した産業分析レポートです。塞栓術粒子のグローバル市場2021 / Global Embolization Particle Sales Market Report 2021 / QAF27664資料のイメージです。• レポートコード:QAF27664
• 出版社/出版日:QYResearch / 2021年5月20日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、134ページ
• 納品方法:Eメール(即日納品)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥592,000 (USD4,000)▷ お問い合わせ
  Multi User¥888,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,184,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本市場調査資料では、世界の塞栓術粒子市場について種類別(ミクロスフェア、粒子(PVA粒子、ゲルフォーム粒子など)、薬剤溶出性ビーズ(DEB)、放射性塞栓ミクロスフェア(Therasphere、SIRSphereなど))、用途別(子宮筋腫塞栓術、前立腺動脈塞栓術(良性前立腺肥大症/BPH治療)、肝腫瘍塞栓術、外傷塞栓術、その他)、地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2016年~2027年までの市場規模と予測(販売量、売上、価格)、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・塞栓術粒子市場の概要
・世界の主要地域別塞栓術粒子市場規模2016-2027
・主要プレイヤーの競争状況・市場シェア
・世界の塞栓術粒子市場規模2016-2021:種類別(ミクロスフェア、粒子(PVA粒子、ゲルフォーム粒子など)、薬剤溶出性ビーズ(DEB)、放射性塞栓ミクロスフェア(Therasphere、SIRSphereなど))
・世界の塞栓術粒子市場予測2012-2027:種類別(ミクロスフェア、粒子(PVA粒子、ゲルフォーム粒子など)、薬剤溶出性ビーズ(DEB)、放射性塞栓ミクロスフェア(Therasphere、SIRSphereなど))
・世界の塞栓術粒子市場規模2016-2021:用途別(子宮筋腫塞栓術、前立腺動脈塞栓術(良性前立腺肥大症/BPH治療)、肝腫瘍塞栓術、外傷塞栓術、その他)
・世界の塞栓術粒子市場予測2012-2027:用途別(子宮筋腫塞栓術、前立腺動脈塞栓術(良性前立腺肥大症/BPH治療)、肝腫瘍塞栓術、外傷塞栓術、その他)
・塞栓術粒子のアメリカ市場規模と予測2016-2021
・塞栓術粒子のヨーロッパ市場規模と予測2016-2021
・塞栓術粒子の中国市場規模と予測2016-2021
・塞栓術粒子の日本市場規模と予測2016-2021
・塞栓術粒子の東南アジア市場規模と予測2016-2021
・塞栓術粒子のインド市場規模と予測2016-2021
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(Sirtex Medical、Merit Medical、Cook Medical、BTG Medical、Boston Scientific Corporation、Terumo Corporation、HENGRUI Medical、INterface BIOmaterials B.V.、Alicon)
・塞栓術粒子の製造コスト分析
・販売チャネル、流通業者、顧客
・塞栓術粒子の市場動向・機会・課題
・調査の結論

Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.
USA has the largest global export quantity and manufacturers in Embolization Particle market, while the Europe is the second sales volume market for Embolization Particle in 2016.

Market Analysis and Insights: Global Embolization Particle Market
The global Embolization Particle market was valued at US$ 1984.9 in 2020 and will reach US$ 4265.8 million by the end of 2027, growing at a CAGR of 13.6% during 2022-2027.

Global Embolization Particle Scope and Market Size
The global Embolization Particle market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Embolization Particle market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Microspheres
Particles (e.g. PVA Particles, Gelfoam Particles)
Drug-eluting Beads (DEBs)
Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)

Segment by Application
Uterine Fibroid Embolization
Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
Liver Tumor Embolization
Trauma Embolization
Other

The Embolization Particle market is analysed and market size information is provided by regions (countries). Segment by Application, the Embolization Particle market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Sirtex Medical
Merit Medical
Cook Medical
BTG Medical
Boston Scientific Corporation
Terumo Corporation
HENGRUI Medical
INterface BIOmaterials B.V.
Alicon

レポート目次

1 Embolization Particle Market Overview
1.1 Embolization Particle Product Scope
1.2 Embolization Particle Segment by Type
1.2.1 Global Embolization Particle Sales by Type (2016 & 2021 & 2027)
1.2.2 Microspheres
1.2.3 Particles (e.g. PVA Particles, Gelfoam Particles)
1.2.4 Drug-eluting Beads (DEBs)
1.2.5 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
1.3 Embolization Particle Segment by Application
1.3.1 Global Embolization Particle Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Uterine Fibroid Embolization
1.3.3 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
1.3.4 Liver Tumor Embolization
1.3.5 Trauma Embolization
1.3.6 Other
1.4 Embolization Particle Market Estimates and Forecasts (2016-2027)
1.4.1 Global Embolization Particle Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Embolization Particle Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Embolization Particle Price Trends (2016-2027)

2 Embolization Particle Estimates and Forecasts by Region
2.1 Global Embolization Particle Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Embolization Particle Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Embolization Particle Sales Market Share by Region (2016-2021)
2.2.2 Global Embolization Particle Revenue Market Share by Region (2016-2021)
2.3 Global Embolization Particle Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Embolization Particle Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Embolization Particle Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Embolization Particle Estimates and Projections (2016-2027)
2.4.2 Europe Embolization Particle Estimates and Projections (2016-2027)
2.4.3 China Embolization Particle Estimates and Projections (2016-2027)
2.4.4 Japan Embolization Particle Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Embolization Particle Estimates and Projections (2016-2027)
2.4.6 India Embolization Particle Estimates and Projections (2016-2027)
3 Global Embolization Particle Competition Landscape by Players
3.1 Global Top Embolization Particle Players by Sales (2016-2021)
3.2 Global Top Embolization Particle Players by Revenue (2016-2021)
3.3 Global Embolization Particle Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Embolization Particle as of 2020)
3.4 Global Embolization Particle Average Price by Company (2016-2021)
3.5 Manufacturers Embolization Particle Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Embolization Particle Market Size by Type
4.1 Global Embolization Particle Historic Market Review by Type (2016-2021)
4.1.1 Global Embolization Particle Sales Market Share by Type (2016-2021)
4.1.2 Global Embolization Particle Revenue Market Share by Type (2016-2021)
4.1.3 Global Embolization Particle Price by Type (2016-2021)
4.2 Global Embolization Particle Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Embolization Particle Sales Forecast by Type (2022-2027)
4.2.2 Global Embolization Particle Revenue Forecast by Type (2022-2027)
4.2.3 Global Embolization Particle Price Forecast by Type (2022-2027)
5 Global Embolization Particle Market Size by Application
5.1 Global Embolization Particle Historic Market Review by Application (2016-2021)
5.1.1 Global Embolization Particle Sales Market Share by Application (2016-2021)
5.1.2 Global Embolization Particle Revenue Market Share by Application (2016-2021)
5.1.3 Global Embolization Particle Price by Application (2016-2021)
5.2 Global Embolization Particle Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Embolization Particle Sales Forecast by Application (2022-2027)
5.2.2 Global Embolization Particle Revenue Forecast by Application (2022-2027)
5.2.3 Global Embolization Particle Price Forecast by Application (2022-2027)

6 North America Embolization Particle Market Facts & Figures
6.1 North America Embolization Particle Sales by Company
6.1.1 North America Embolization Particle Sales by Company (2016-2021)
6.1.2 North America Embolization Particle Revenue by Company (2016-2021)
6.2 North America Embolization Particle Sales Breakdown by Type
6.2.1 North America Embolization Particle Sales Breakdown by Type (2016-2021)
6.2.2 North America Embolization Particle Sales Breakdown by Type (2022-2027)
6.3 North America Embolization Particle Sales Breakdown by Application
6.3.1 North America Embolization Particle Sales Breakdown by Application (2016-2021)
6.3.2 North America Embolization Particle Sales Breakdown by Application (2022-2027)

7 Europe Embolization Particle Market Facts & Figures
7.1 Europe Embolization Particle Sales by Company
7.1.1 Europe Embolization Particle Sales by Company (2016-2021)
7.1.2 Europe Embolization Particle Revenue by Company (2016-2021)
7.2 Europe Embolization Particle Sales Breakdown by Type
7.2.1 Europe Embolization Particle Sales Breakdown by Type (2016-2021)
7.2.2 Europe Embolization Particle Sales Breakdown by Type (2022-2027)
7.3 Europe Embolization Particle Sales Breakdown by Application
7.3.1 Europe 134 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 134 Sales Breakdown by Application (2022-2027)

8 China Embolization Particle Market Facts & Figures
8.1 China Embolization Particle Sales by Company
8.1.1 China Embolization Particle Sales by Company (2016-2021)
8.1.2 China Embolization Particle Revenue by Company (2016-2021)
8.2 China Embolization Particle Sales Breakdown by Type
8.2.1 China Embolization Particle Sales Breakdown by Type (2016-2021)
8.2.2 China Embolization Particle Sales Breakdown by Type (2022-2027)
8.3 China Embolization Particle Sales Breakdown by Application
8.3.1 China 244 Sales Breakdown by Application (2016-2021)
8.3.2 China 244 Sales Breakdown by Application (2022-2027)

9 Japan Embolization Particle Market Facts & Figures
9.1 Japan Embolization Particle Sales by Company
9.1.1 Japan Embolization Particle Sales by Company (2016-2021)
9.1.2 Japan Embolization Particle Revenue by Company (2016-2021)
9.2 Japan Embolization Particle Sales Breakdown by Type
9.2.1 Japan Embolization Particle Sales Breakdown by Type (2016-2021)
9.2.2 Japan Embolization Particle Sales Breakdown by Type (2022-2027)
9.3 Japan Embolization Particle Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Embolization Particle Market Facts & Figures
10.1 Southeast Asia Embolization Particle Sales by Company
10.1.1 Southeast Asia Embolization Particle Sales by Company (2016-2021)
10.1.2 Southeast Asia Embolization Particle Revenue by Company (2016-2021)
10.2 Southeast Asia Embolization Particle Sales Breakdown by Type
10.2.1 Southeast Asia Embolization Particle Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Embolization Particle Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Embolization Particle Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Embolization Particle Market Facts & Figures
11.1 India Embolization Particle Sales by Company
11.1.1 India Embolization Particle Sales by Company (2016-2021)
11.1.2 India Embolization Particle Revenue by Company (2016-2021)
11.2 India Embolization Particle Sales Breakdown by Type
11.2.1 India Embolization Particle Sales Breakdown by Type (2016-2021)
11.2.2 India Embolization Particle Sales Breakdown by Type (2022-2027)
11.3 India Embolization Particle Sales Breakdown by Application
11.3.1 India Embolization Particle Sales Breakdown by Application (2016-2021)
11.3.2 India Embolization Particle Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Embolization Particle Business
12.1 Sirtex Medical
12.1.1 Sirtex Medical Corporation Information
12.1.2 Sirtex Medical Business Overview
12.1.3 Sirtex Medical Embolization Particle Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Sirtex Medical Embolization Particle Products Offered
12.1.5 Sirtex Medical Recent Development
12.2 Merit Medical
12.2.1 Merit Medical Corporation Information
12.2.2 Merit Medical Business Overview
12.2.3 Merit Medical Embolization Particle Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Merit Medical Embolization Particle Products Offered
12.2.5 Merit Medical Recent Development
12.3 Cook Medical
12.3.1 Cook Medical Corporation Information
12.3.2 Cook Medical Business Overview
12.3.3 Cook Medical Embolization Particle Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Cook Medical Embolization Particle Products Offered
12.3.5 Cook Medical Recent Development
12.4 BTG Medical
12.4.1 BTG Medical Corporation Information
12.4.2 BTG Medical Business Overview
12.4.3 BTG Medical Embolization Particle Sales, Revenue and Gross Margin (2016-2021)
12.4.4 BTG Medical Embolization Particle Products Offered
12.4.5 BTG Medical Recent Development
12.5 Boston Scientific Corporation
12.5.1 Boston Scientific Corporation Corporation Information
12.5.2 Boston Scientific Corporation Business Overview
12.5.3 Boston Scientific Corporation Embolization Particle Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Boston Scientific Corporation Embolization Particle Products Offered
12.5.5 Boston Scientific Corporation Recent Development
12.6 Terumo Corporation
12.6.1 Terumo Corporation Corporation Information
12.6.2 Terumo Corporation Business Overview
12.6.3 Terumo Corporation Embolization Particle Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Terumo Corporation Embolization Particle Products Offered
12.6.5 Terumo Corporation Recent Development
12.7 HENGRUI Medical
12.7.1 HENGRUI Medical Corporation Information
12.7.2 HENGRUI Medical Business Overview
12.7.3 HENGRUI Medical Embolization Particle Sales, Revenue and Gross Margin (2016-2021)
12.7.4 HENGRUI Medical Embolization Particle Products Offered
12.7.5 HENGRUI Medical Recent Development
12.8 INterface BIOmaterials B.V.
12.8.1 INterface BIOmaterials B.V. Corporation Information
12.8.2 INterface BIOmaterials B.V. Business Overview
12.8.3 INterface BIOmaterials B.V. Embolization Particle Sales, Revenue and Gross Margin (2016-2021)
12.8.4 INterface BIOmaterials B.V. Embolization Particle Products Offered
12.8.5 INterface BIOmaterials B.V. Recent Development
12.9 Alicon
12.9.1 Alicon Corporation Information
12.9.2 Alicon Business Overview
12.9.3 Alicon Embolization Particle Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Alicon Embolization Particle Products Offered
12.9.5 Alicon Recent Development

13 Embolization Particle Manufacturing Cost Analysis
13.1 Embolization Particle Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Embolization Particle
13.4 Embolization Particle Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Embolization Particle Distributors List
14.3 Embolization Particle Customers

15 Market Dynamics
15.1 Embolization Particle Market Trends
15.2 Embolization Particle Drivers
15.3 Embolization Particle Market Challenges
15.4 Embolization Particle Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Embolization Particle Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Embolization Particle Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Embolization Particle Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Embolization Particle Sales (K Units) by Region (2016-2021)
Table 5. Global Embolization Particle Sales Market Share by Region (2016-2021)
Table 6. Global Embolization Particle Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Embolization Particle Revenue Share by Region (2016-2021)
Table 8. Global Embolization Particle Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Embolization Particle Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Embolization Particle Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Embolization Particle Revenue Share Forecast by Region (2022-2027)
Table 12. Global Embolization Particle Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Embolization Particle Sales Share by Company (2016-2021)
Table 14. Global Embolization Particle Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Embolization Particle Revenue Share by Company (2016-2021)
Table 16. Global Embolization Particle by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Embolization Particle as of 2020)
Table 17. Global Embolization Particle Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Embolization Particle Manufacturing Sites and Area Served
Table 19. Manufacturers Embolization Particle Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Embolization Particle Sales (K Units) by Type (2016-2021)
Table 22. Global Embolization Particle Sales Share by Type (2016-2021)
Table 23. Global Embolization Particle Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Embolization Particle Price (USD/Unit) by Type (2016-2021)
Table 25. Global Embolization Particle Sales Share by Type (2022-2027)
Table 26. Global Embolization Particle Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Embolization Particle Revenue Share by Type (2022-2027)
Table 28. Global Embolization Particle Price (USD/Unit) by Type (2022-2027)
Table 29. Global Embolization Particle Sales (K Units) by Application (2016-2021)
Table 30. Global Embolization Particle Sales Share by Application (2016-2021)
Table 31. Global Embolization Particle Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Embolization Particle Price (USD/Unit) by Application (2016-2021)
Table 33. Global Embolization Particle Sales (K Units) by Application (2022-2027)
Table 34. Global Embolization Particle Sales Share by Application (2022-2027)
Table 35. Global Embolization Particle Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Embolization Particle Revenue Share by Application (2022-2027)
Table 37. Global Embolization Particle Price (USD/Unit) by Application (2022-2027)
Table 38. North America Embolization Particle Sales (K Units) by Company (2016-2021)
Table 39. North America Embolization Particle Sales Market Share by Company (2016-2021)
Table 40. North America Embolization Particle Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Embolization Particle Revenue Market Share by Company (2016-2021)
Table 42. North America Embolization Particle Sales by Type (2016-2021) & (K Units)
Table 43. North America Embolization Particle Sales Market Share by Type (2016-2021)
Table 44. North America Embolization Particle Sales by Type (2022-2027) & (K Units)
Table 45. North America Embolization Particle Sales Market Share by Type (2022-2027)
Table 46. North America Embolization Particle Sales by Application (2016-2021) & (K Units)
Table 47. North America Embolization Particle Sales Market Share by Application (2016-2021)
Table 48. North America Embolization Particle Sales by Application (2022-2027) & (K Units)
Table 49. North America Embolization Particle Sales Market Share by Application (2022-2027)
Table 50. Europe Embolization Particle Sales (K Units) by Company (2016-2021)
Table 51. Europe Embolization Particle Sales Market Share by Company (2016-2021)
Table 52. Europe Embolization Particle Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Embolization Particle Revenue Market Share by Company (2016-2021)
Table 54. Europe Embolization Particle Sales by Type (2016-2021) & (K Units)
Table 55. Europe Embolization Particle Sales Market Share by Type (2016-2021)
Table 56. Europe Embolization Particle Sales by Type (2022-2027) & (K Units)
Table 57. Europe Embolization Particle Sales Market Share by Type (2022-2027)
Table 58. Europe Embolization Particle Sales by Application (2016-2021) & (K Units)
Table 59. Europe Embolization Particle Sales Market Share by Application (2016-2021)
Table 60. Europe Embolization Particle Sales by Application (2022-2027) & (K Units)
Table 61. Europe Embolization Particle Sales Market Share by Application (2022-2027)
Table 62. China Embolization Particle Sales (K Units) by Company (2016-2021)
Table 63. China Embolization Particle Sales Market Share by Company (2016-2021)
Table 64. China Embolization Particle Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Embolization Particle Revenue Market Share by Company (2016-2021)
Table 66. China Embolization Particle Sales by Type (2016-2021) & (K Units)
Table 67. China Embolization Particle Sales Market Share by Type (2016-2021)
Table 68. China Embolization Particle Sales by Type (2022-2027) & (K Units)
Table 69. China Embolization Particle Sales Market Share by Type (2022-2027)
Table 70. China Embolization Particle Sales by Application (2016-2021) & (K Units)
Table 71. China Embolization Particle Sales Market Share by Application (2016-2021)
Table 72. China Embolization Particle Sales by Application (2022-2027) & (K Units)
Table 73. China Embolization Particle Sales Market Share by Application (2022-2027)
Table 74. Japan Embolization Particle Sales (K Units) by Company (2016-2021)
Table 75. Japan Embolization Particle Sales Market Share by Company (2016-2021)
Table 76. Japan Embolization Particle Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Embolization Particle Revenue Market Share by Company (2016-2021)
Table 78. Japan Embolization Particle Sales by Type (2016-2021) & (K Units)
Table 79. Japan Embolization Particle Sales Market Share by Type (2016-2021)
Table 80. Japan Embolization Particle Sales by Type (2022-2027) & (K Units)
Table 81. Japan Embolization Particle Sales Market Share by Type (2022-2027)
Table 82. Japan Embolization Particle Sales by Application (2016-2021) & (K Units)
Table 83. Japan Embolization Particle Sales Market Share by Application (2016-2021)
Table 84. Japan Embolization Particle Sales by Application (2022-2027) & (K Units)
Table 85. Japan Embolization Particle Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Embolization Particle Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Embolization Particle Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Embolization Particle Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Embolization Particle Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Embolization Particle Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Embolization Particle Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Embolization Particle Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Embolization Particle Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Embolization Particle Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Embolization Particle Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Embolization Particle Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Embolization Particle Sales Market Share by Application (2022-2027)
Table 98. India Embolization Particle Sales (K Units) by Company (2016-2021)
Table 99. India Embolization Particle Sales Market Share by Company (2016-2021)
Table 100. India Embolization Particle Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Embolization Particle Revenue Market Share by Company (2016-2021)
Table 102. India Embolization Particle Sales by Type (2016-2021) & (K Units)
Table 103. India Embolization Particle Sales Market Share by Type (2016-2021)
Table 104. India Embolization Particle Sales by Type (2022-2027) & (K Units)
Table 105. India Embolization Particle Sales Market Share by Type (2022-2027)
Table 106. India Embolization Particle Sales by Application (2016-2021) & (K Units)
Table 107. India Embolization Particle Sales Market Share by Application (2016-2021)
Table 108. India Embolization Particle Sales by Application (2022-2027) & (K Units)
Table 109. India Embolization Particle Sales Market Share by Application (2022-2027)
Table 110. Sirtex Medical Corporation Information
Table 111. Sirtex Medical Description and Business Overview
Table 112. Sirtex Medical Embolization Particle Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Sirtex Medical Embolization Particle Product
Table 114. Sirtex Medical Recent Development
Table 115. Merit Medical Corporation Information
Table 116. Merit Medical Description and Business Overview
Table 117. Merit Medical Embolization Particle Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Merit Medical Embolization Particle Product
Table 119. Merit Medical Recent Development
Table 120. Cook Medical Corporation Information
Table 121. Cook Medical Description and Business Overview
Table 122. Cook Medical Embolization Particle Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Cook Medical Embolization Particle Product
Table 124. Cook Medical Recent Development
Table 125. BTG Medical Corporation Information
Table 126. BTG Medical Description and Business Overview
Table 127. BTG Medical Embolization Particle Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. BTG Medical Embolization Particle Product
Table 129. BTG Medical Recent Development
Table 130. Boston Scientific Corporation Corporation Information
Table 131. Boston Scientific Corporation Description and Business Overview
Table 132. Boston Scientific Corporation Embolization Particle Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Boston Scientific Corporation Embolization Particle Product
Table 134. Boston Scientific Corporation Recent Development
Table 135. Terumo Corporation Corporation Information
Table 136. Terumo Corporation Description and Business Overview
Table 137. Terumo Corporation Embolization Particle Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Terumo Corporation Embolization Particle Product
Table 139. Terumo Corporation Recent Development
Table 140. HENGRUI Medical Corporation Information
Table 141. HENGRUI Medical Description and Business Overview
Table 142. HENGRUI Medical Embolization Particle Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. HENGRUI Medical Embolization Particle Product
Table 144. HENGRUI Medical Recent Development
Table 145. INterface BIOmaterials B.V. Corporation Information
Table 146. INterface BIOmaterials B.V. Embolization Particle Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. INterface BIOmaterials B.V. Description and Business Overview
Table 148. INterface BIOmaterials B.V. Embolization Particle Product
Table 149. INterface BIOmaterials B.V. Recent Development
Table 150. Alicon Corporation Information
Table 151. Alicon Embolization Particle Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Alicon Description and Business Overview
Table 153. Alicon Embolization Particle Product
Table 154. Alicon Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Embolization Particle Distributors List
Table 158. Embolization Particle Customers List
Table 159. Embolization Particle Market Trends
Table 160. Embolization Particle Market Drivers
Table 161. Embolization Particle Market Challenges
Table 162. Embolization Particle Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Embolization Particle Product Picture
Figure 2. Global Embolization Particle Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Embolization Particle Sales Market Share by Application in 2021 & 2027
Figure 6. Uterine Fibroid Embolization Examples
Figure 7. Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH) Examples
Figure 8. Liver Tumor Embolization Examples
Figure 9. Trauma Embolization Examples
Figure 10. Other Examples
Figure 11. Global Embolization Particle Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Embolization Particle Sales Growth Rate (2016-2027) & (US$ Million)
Figure 13. Global Embolization Particle Sales (K Units) Growth Rate (2016-2027)
Figure 14. Global Embolization Particle Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 15. Global Embolization Particle Revenue Market Share by Region: 2016 VS 2021
Figure 16. Global Embolization Particle Revenue Market Share by Region: 2021 VS 2027
Figure 17. North America Embolization Particle Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. North America Embolization Particle Sales (K Units) Growth Rate (2016-2027)
Figure 19. Europe Embolization Particle Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. Europe Embolization Particle Sales (Million USD) Growth Rate (2016-2027)
Figure 21. China Embolization Particle Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. China Embolization Particle Sales (Million USD) and Growth Rate (2016-2027)
Figure 23. Japan Embolization Particle Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Japan Embolization Particle Sales (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Embolization Particle Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. Southeast Asia Embolization Particle Sales (Million USD) Growth Rate (2016-2027)
Figure 27. India Embolization Particle Revenue (Million USD) Growth Rate (2016-2027)
Figure 28. India Embolization Particle Sales (Million USD) Growth Rate (2016-2027)
Figure 29. Global 5 Largest Embolization Particle Players Market Share by Revenue in Embolization Particle: 2016 & 2020
Figure 30. Embolization Particle Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 31. Global Embolization Particle Revenue Share by Type (2016-2021)
Figure 32. Global Embolization Particle Revenue Growth Rate by Type in 2016 & 2020
Figure 33. Global Embolization Particle Revenue Share by Application (2016-2021)
Figure 34. Global Embolization Particle Revenue Growth Rate by Application in 2016 & 2020
Figure 35. North America Embolization Particle Sales Market Share by Type in 2020
Figure 36. North America Embolization Particle Sales Market Share by Application in 2020
Figure 37. Europe Embolization Particle Sales Market Share by Type in 2020
Figure 38. Europe Embolization Particle Sales Market Share by Application in 2020
Figure 39. China Embolization Particle Sales Market Share by Type in 2020
Figure 40. China Embolization Particle Sales Market Share by Application in 2020
Figure 41. Japan Embolization Particle Sales Market Share by Type in 2020
Figure 42. Japan Embolization Particle Sales Market Share by Application in 2020
Figure 43. Southeast Asia Embolization Particle Sales Market Share by Type in 2020
Figure 44. Southeast Asia Embolization Particle Sales Market Share by Application in 2020
Figure 45. India Embolization Particle Sales Market Share by Type in 2020
Figure 46. India Embolization Particle Sales Market Share by Application in 2020
Figure 47. Key Raw Materials Price Trend
Figure 48. Manufacturing Cost Structure of Embolization Particle
Figure 49. Manufacturing Process Analysis of Embolization Particle
Figure 50. Embolization Particle Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed